Mark Rothera - President and CEO, Director at Viracta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
VIRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark Rothera - trading volume in the past year for Viracta Therapeutics, Inc.

Holdings reported by Mark Rothera for Viracta Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 100K $49.3K $0.49 Dec 1, 2023 Direct
Stock Option (Right to Buy) 475K Mar 12, 2024 Direct Common Stock

Transactions reported by Mark Rothera for Viracta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.